Ketoprofen topical - Celtic Pharma

Drug Profile

Ketoprofen topical - Celtic Pharma

Alternative Names: TDT-070

Latest Information Update: 20 Aug 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator IDEA
  • Developer Celtic Pharma
  • Class Analgesics; Anti-inflammatories
  • Mechanism of Action Cyclooxygenase inhibitors; Lipoxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Photodamage; Skin disorders

Most Recent Events

  • 20 Jun 2008 Clinical development is ongoing
  • 23 Feb 2006 IDEA 070 has been licensed to Celtic Pharma worldwide
  • 18 Mar 2005 Data presented at the 63rd Annual Meeting of the American Academy of Dermatology (AAD-2005) have been added to the adverse events and Skin disorders therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top